3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 4
1
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Conditions
Spondylitis, Ankylosing
2
Psoriasis
2
Colitis, Ulcerative
2
Plaque Psoriasis
1
Osteoarthritis
1
Hidradenitis Suppurativa
1
Crohn Disease
1
Acne Vulgaris
1
Abscess
1
Interventions
tofacitinib
7
Etanercept
4
Adalimumab
2
secukinumab
1
apremilast
1
Methotrexate
1
Anti-Infective Agents, Local
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Psoriasis
×
Adalimumab
×
Clear all
NCT02762955
2021-09-08
CALYPSO
Biocad
Phase 3
Completed
344 enrolled
NCT02196701
2018-03-19
CLEAR
AbbVie
Phase 3
Completed
46 enrolled
27 charts